Margaret Beaudoin, Vice President, Finance at Verve Therapeutics, Inc. (VERV), bought 1,000 shares at $19.00 ($19K) on 2021-06-21, disclosed to the SEC on 2021-06-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.